Detalles
This document provides additional guidance in the pharmaceutical and biotechnology sector. This covers: The assessment of nature-related issues using the TNFD's LEAP approach and the disclosure of sector-specific metrics in line with the approach recommended by the TNFD.
Recursos relacionados
Integrating biodiversity into private equity. Feedback and case studies
The integration of biodiversity issues by private capital actors is a major challenge, in response to new regulations and the…
Sustainable finance in Spain, within the framework of the European Union and in the international context
The aim of this paper is to present a general, up-to-date overview of sustainable finance in Spain, within the framework…